BlackRock Health Sciences Trust (BME) — Capital Reinvestment Ratio
BlackRock Health Sciences Trust (BME) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($959.34K) in capital expenditures ($5.00). Check tangible equity quality of BlackRock Health Sciences Trust to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BlackRock Health Sciences Trust Capital Reinvestment Ratio (2023–2023)
This chart tracks BlackRock Health Sciences Trust's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see BME cash flow metrics.
Annual Capital Reinvestment Ratio for BlackRock Health Sciences Trust (2023–2023)
Year-by-year Capital Reinvestment Ratio for BlackRock Health Sciences Trust from 2023 to 2023. See BME FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.00x | $32.02 Million | $3.00 | — |